Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
Features
01 May 2004
Antony Williams believes that organisations need to recognise the value of organising themselves to integrate chemical structure and analytical information
01 May 2004
The electronic lab notebook has been heralded before, says Peter Rees. But it might just happen this time
01 May 2004
James Truchard believes that performance will improve, while costs and development time will decrease, making engineers more productive through the use of virtual instrumentation
01 May 2004
Chris Randles praises XML as a basis for innovation and technical communication
01 May 2004
Guy Lefever sees seven new technologies, all related to scientific computing, transforming the face of medicine
01 May 2004
Steve Maginn looks at the two ends of the chemistry software industry
01 May 2004
Robert Massie and Ramond D'Angelo believe that, as the physical limitations of processing, storing, and delivering information diminish, the possibilities of the digital research environment keep expanding
01 May 2004
Robert Pavlis believes there has never been a more exciting time in instrument interfacing
01 May 2004
Computational science will go deeper and wider in the next 10 years. But Scott Kahn believes that the most profound changes will come through the integration of methods and domains
01 March 2004
Doctors depend on pathology labs for accurate diagnoses, and path labs depend on ever more sophisticated LIMS, Peter Rees reports
01 March 2004
John Murphy profiles the Director of the Institute of Quantum Computing at Waterloo University, Ontario
01 March 2004
Grid computing won't happen without glue to hold it together, as Michael Kenward finds when investigating middleware
Pages
Latest issue
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
